ISAVUCONAZOLE: 1,413 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
1,413
Total FAERS Reports
481 (34.0%)
Deaths Reported
580
Hospitalizations
1,413
As Primary/Secondary Suspect
107
Life-Threatening
10
Disabilities
First Report: 20081106 · Latest Report: 20250904
What Are the Most Common ISAVUCONAZOLE Side Effects?
#1 Most Reported
Off label use
342 reports (24.2%)
#2 Most Reported
Drug ineffective
224 reports (15.9%)
#3 Most Reported
Death
155 reports (11.0%)
All ISAVUCONAZOLE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 342 | 24.2% | 116 | 121 |
| Drug ineffective | 224 | 15.9% | 112 | 127 |
| Death | 155 | 11.0% | 155 | 21 |
| Product use in unapproved indication | 135 | 9.6% | 47 | 60 |
| Aspergillus infection | 58 | 4.1% | 27 | 38 |
| Condition aggravated | 58 | 4.1% | 27 | 24 |
| Drug interaction | 58 | 4.1% | 13 | 29 |
| Septic shock | 56 | 4.0% | 52 | 27 |
| Nausea | 53 | 3.8% | 7 | 32 |
| Bronchopulmonary aspergillosis | 50 | 3.5% | 22 | 34 |
| Infection | 48 | 3.4% | 18 | 21 |
| Mucormycosis | 48 | 3.4% | 21 | 26 |
| Pyrexia | 42 | 3.0% | 9 | 29 |
| Respiratory failure | 42 | 3.0% | 32 | 27 |
| Drug ineffective for unapproved indication | 36 | 2.6% | 16 | 14 |
| Dyspnoea | 36 | 2.6% | 9 | 16 |
| Febrile neutropenia | 36 | 2.6% | 8 | 25 |
| Vomiting | 36 | 2.6% | 3 | 18 |
| Multiple organ dysfunction syndrome | 35 | 2.5% | 35 | 23 |
| Pneumonia | 35 | 2.5% | 7 | 27 |
Who Reports ISAVUCONAZOLE Side Effects? Age & Gender Data
Gender: 36.6% female, 63.4% male. Average age: 53.5 years. Most reports from: US. View detailed demographics →
Is ISAVUCONAZOLE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2008 | 1 | 0 | 0 |
| 2010 | 1 | 0 | 0 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 3 | 2 | 2 |
| 2015 | 5 | 4 | 3 |
| 2016 | 17 | 5 | 6 |
| 2017 | 59 | 20 | 33 |
| 2018 | 129 | 54 | 64 |
| 2019 | 57 | 19 | 22 |
| 2020 | 70 | 38 | 42 |
| 2021 | 58 | 10 | 25 |
| 2022 | 43 | 4 | 14 |
| 2023 | 76 | 11 | 31 |
| 2024 | 62 | 12 | 24 |
| 2025 | 38 | 2 | 20 |
What Is ISAVUCONAZOLE Used For?
| Indication | Reports |
|---|---|
| Aspergillus infection | 276 |
| Product used for unknown indication | 208 |
| Bronchopulmonary aspergillosis | 195 |
| Mucormycosis | 159 |
| Fungal infection | 115 |
| Antifungal prophylaxis | 90 |
| Prophylaxis | 76 |
| Antifungal treatment | 40 |
| Acute myeloid leukaemia | 32 |
| Pulmonary mucormycosis | 28 |
ISAVUCONAZOLE vs Alternatives: Which Is Safer?
ISAVUCONAZOLE vs ISAVUCONAZONIUM
ISAVUCONAZOLE vs ISCALIMAB
ISAVUCONAZOLE vs ISENTRESS
ISAVUCONAZOLE vs ISOFLURANE
ISAVUCONAZOLE vs ISONIAZID
ISAVUCONAZOLE vs ISONIAZID\PYRAZINAMIDE\RIFAMPIN
ISAVUCONAZOLE vs ISONIAZID\PYRIDOXINE\SULFAMETHOXAZOLE\TRIMETHOPRIM
ISAVUCONAZOLE vs ISONIAZID\RIFAMPIN
ISAVUCONAZOLE vs ISOPROPANOLAMINE
ISAVUCONAZOLE vs ISOPROPYL ALCOHOL
Official FDA Label for ISAVUCONAZOLE
Official prescribing information from the FDA-approved drug label.